Jounce Therapeutics, Inc. Insider Trading for March 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Jounce Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Jounce Therapeutics, Inc. for March 2018.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 19 2018 | JNCE | Jounce Therapeutic ... | Duncan Barbara Gayle | Director | Option Exercise | M | 4.21 | 2,000 | 8,420 | 44,271 | |
Mar 19 2018 | JNCE | Jounce Therapeutic ... | Duncan Barbara Gayle | Director | Sell | S | 28.11 | 2,000 | 56,220 | 0 | 2 K to 0 (-100.00 %) |
Mar 19 2018 | JNCE | Jounce Therapeutic ... | Duncan Barbara Gayle | Director | Buy | M | 4.21 | 2,000 | 8,420 | 2,000 | 0 to 2 K |
Mar 12 2018 | JNCE | Jounce Therapeutic ... | Trehu Elizabeth | Chief Medical Offic ... | Option Exercise | M | 4.02 | 4,545 | 18,271 | 242,260 | |
Mar 12 2018 | JNCE | Jounce Therapeutic ... | Trehu Elizabeth | Chief Medical Offic ... | Sell | S | 25.06 | 4,545 | 113,898 | 0 | 4.5 K to 0 (-100.00 %) |
Mar 12 2018 | JNCE | Jounce Therapeutic ... | Trehu Elizabeth | Chief Medical Offic ... | Buy | M | 4.02 | 4,545 | 18,271 | 4,545 | 0 to 4.5 K |
Mar 12 2018 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Option Exercise | M | 0.48 | 16,334 | 7,840 | 857,169 | |
Mar 12 2018 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Sell | S | 25.10 | 16,334 | 409,983 | 0 | 16.3 K to 0 (-100.00 %) |
Mar 12 2018 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Buy | M | 0.48 | 16,334 | 7,840 | 16,334 | 0 to 16.3 K |
Mar 12 2018 | JNCE | Jounce Therapeutic ... | Drapkin Kimberlee C | CFO and Treasurer | Option Exercise | M | 0.48 | 3,759 | 1,804 | 3,016 | |
Mar 12 2018 | JNCE | Jounce Therapeutic ... | Drapkin Kimberlee C | CFO and Treasurer | Sell | S | 25.01 | 5,267 | 131,728 | 0 | 5.3 K to 0 (-100.00 %) |
Mar 12 2018 | JNCE | Jounce Therapeutic ... | Drapkin Kimberlee C | CFO and Treasurer | Buy | M | 0.48 | 3,759 | 1,804 | 5,267 | 1.5 K to 5.3 K (+249.27 %) |
Mar 07 2018 | JNCE | Jounce Therapeutic ... | Trehu Elizabeth | Chief Medical Offic ... | Option Exercise | M | 4.02 | 4,545 | 18,271 | 246,805 | |
Mar 07 2018 | JNCE | Jounce Therapeutic ... | Trehu Elizabeth | Chief Medical Offic ... | Sell | S | 22.11 | 1,366 | 30,202 | 0 | 1.4 K to 0 (-100.00 %) |
Mar 07 2018 | JNCE | Jounce Therapeutic ... | Trehu Elizabeth | Chief Medical Offic ... | Sell | S | 21.24 | 3,179 | 67,522 | 1,366 | 4.5 K to 1.4 K (-69.94 %) |
Mar 07 2018 | JNCE | Jounce Therapeutic ... | Trehu Elizabeth | Chief Medical Offic ... | Buy | M | 4.02 | 4,545 | 18,271 | 4,545 | 0 to 4.5 K |
Mar 07 2018 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Option Exercise | M | 0.48 | 16,334 | 7,840 | 873,503 | |
Mar 07 2018 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Sell | S | 22.06 | 4,234 | 93,402 | 0 | 4.2 K to 0 (-100.00 %) |
Mar 07 2018 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Sell | S | 21.21 | 12,100 | 256,641 | 4,234 | 16.3 K to 4.2 K (-74.08 %) |
Mar 07 2018 | JNCE | Jounce Therapeutic ... | MURRAY RICHARD /CA/ | CEO and President | Buy | M | 0.48 | 16,334 | 7,840 | 16,334 | 0 to 16.3 K |
Mar 07 2018 | JNCE | Jounce Therapeutic ... | Drapkin Kimberlee C | CFO and Treasurer | Sell | S | 22.07 | 1,267 | 27,963 | 1,508 | 2.8 K to 1.5 K (-45.66 %) |
Mar 07 2018 | JNCE | Jounce Therapeutic ... | Drapkin Kimberlee C | CFO and Treasurer | Sell | S | 21.21 | 4,000 | 84,840 | 2,775 | 6.8 K to 2.8 K (-59.04 %) |